CS logo
small CS logo
Japanese Red Cross Kumamoto Hospital

Kumamoto, Japan
General hospital in Kumamoto
2 Chome-1-1 Nagamineminami, Higashi Ward, Kumamoto, 861-8520

About Japanese Red Cross Kumamoto Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Japanese Red Cross Kumamoto Hospital


During the past decade, Japanese Red Cross Kumamoto Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 9 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years333322555544000011003322Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
2011-09-01
2016-12-01
Unknown status
1,000
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Clostridium Difficile Vaccine Efficacy Trial
2017-03-29
2021-12-21
Completed
17,535
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
2018-01-24
2021-06-30
Terminated
103

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Japanese Red Cross Kumamoto Hospital" #1 sponsor was "Bayer" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Kumamoto Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 8Bayer: 8Boehringer Ingelheim: 4Boehringer Ingelheim: 4Pfizer: 3Pfizer: 3Arena Pharmaceuticals: 2Arena Pharmaceuticals: 2Takeda: 2Takeda: 2Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2ASKA PharmaceuticalCo., Ltd.: 1ASKA PharmaceuticalCo., Ltd.: 1Janssen Pharmaceutical K.K.: 1Janssen Pharmaceutical K.K.: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Ministry of Health,Labour and Welfare,Japan: 1Ministry of Health,Labour and Welfare,Japan: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3Arena is a whollyowned subsidiary ofPfizer: 2Arena is a whollyowned subsidiary ofPfizer: 2Tokyo Medical andDental University: 2Tokyo Medical andDental University: 2Population HealthResearch Institute: 1Population HealthResearch Institute: 1

Clinical Trials Conditions at Japanese Red Cross Kumamoto Hospital


According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Kumamoto Hospital" are "Ulcerative Colitis" (4 trials), "Endometriosis" (3 trials), "Chronic Kidney Disease" (2 trials), "Colorectal Cancer" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Japanese Red Cross Kumamoto Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Japanese Red Cross Kumamoto Hospital


Most popular intervention types in "Japanese Red Cross Kumamoto Hospital" are "Drug" (23 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Empagliflozin" (4 trials), "Etrasimod" (4 trials), "Vilaprisan (BAY1002670)" (3 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Japanese Red Cross Kumamoto Hospital


The vast majority of trials in "Japanese Red Cross Kumamoto Hospital" are 21 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Japanese Red Cross Kumamoto Hospital


Currently, there are NaN active trials in "Japanese Red Cross Kumamoto Hospital". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Japanese Red Cross Kumamoto Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Kumamoto Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 7Phase 2: 7Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Recruiting: 9Recruiting: 9Terminated: 2Terminated: 2Active, not recruiting: 1Active, not recruiting: 1Unknown status: 1Unknown status: 1Withdrawn: 1Withdrawn: 1